Table of Contents 1 Combination Vaccine Market Overview 1.1 Product Overview and Scope of Combination Vaccine 1.2 Combination Vaccine Segment by Type 1.2.1 Global Combination Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Meningococcal Vaccine 1.2.3 Japanese Encephalitis Vaccine 1.2.4 Yellow Fever Vaccine 1.2.5 Hepatitis Vaccine 1.2.6 Cholera Vaccine 1.2.7 Other 1.3 Combination Vaccine Segment by Application 1.3.1 Combination Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 Adults 1.3.3 Children 1.4 Global Combination Vaccine Market Size Estimates and Forecasts 1.4.1 Global Combination Vaccine Revenue 2015-2026 1.4.2 Global Combination Vaccine Sales 2015-2026 1.4.3 Combination Vaccine Market Size by Region: 2020 Versus 2026 2 Global Combination Vaccine Market Competition by Manufacturers 2.1 Global Combination Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Combination Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Combination Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Combination Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Combination Vaccine Market Competitive Situation and Trends 2.5.1 Combination Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Combination Vaccine Players (Opinion Leaders) 3 Combination Vaccine Retrospective Market Scenario by Region 3.1 Global Combination Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Combination Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Combination Vaccine Market Facts & Figures by Country 3.3.1 North America Combination Vaccine Sales by Country 3.3.2 North America Combination Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Combination Vaccine Market Facts & Figures by Country 3.4.1 Europe Combination Vaccine Sales by Country 3.4.2 Europe Combination Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Combination Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Combination Vaccine Sales by Region 3.5.2 Asia Pacific Combination Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Combination Vaccine Market Facts & Figures by Country 3.6.1 Latin America Combination Vaccine Sales by Country 3.6.2 Latin America Combination Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Combination Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Combination Vaccine Sales by Country 3.7.2 Middle East and Africa Combination Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Combination Vaccine Historic Market Analysis by Type 4.1 Global Combination Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Combination Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Combination Vaccine Price Market Share by Type (2015-2020) 4.4 Global Combination Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Combination Vaccine Historic Market Analysis by Application 5.1 Global Combination Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Combination Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Combination Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Combination Vaccine Business 6.1 GSK 6.1.1 Corporation Information 6.1.2 GSK Description, Business Overview and Total Revenue 6.1.3 GSK Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 GSK Products Offered 6.1.5 GSK Recent Development 6.2 Sanofi Pasteur 6.2.1 Sanofi Pasteur Combination Vaccine Production Sites and Area Served 6.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue 6.2.3 Sanofi Pasteur Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Sanofi Pasteur Products Offered 6.2.5 Sanofi Pasteur Recent Development 6.3 Merck 6.3.1 Merck Combination Vaccine Production Sites and Area Served 6.3.2 Merck Description, Business Overview and Total Revenue 6.3.3 Merck Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Merck Products Offered 6.3.5 Merck Recent Development 6.4 Pfizer 6.4.1 Pfizer Combination Vaccine Production Sites and Area Served 6.4.2 Pfizer Description, Business Overview and Total Revenue 6.4.3 Pfizer Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Pfizer Products Offered 6.4.5 Pfizer Recent Development 6.5 CNBG 6.5.1 CNBG Combination Vaccine Production Sites and Area Served 6.5.2 CNBG Description, Business Overview and Total Revenue 6.5.3 CNBG Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 CNBG Products Offered 6.5.5 CNBG Recent Development 6.6 Sanofi Pasteur MSD 6.6.1 Sanofi Pasteur MSD Combination Vaccine Production Sites and Area Served 6.6.2 Sanofi Pasteur MSD Description, Business Overview and Total Revenue 6.6.3 Sanofi Pasteur MSD Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Sanofi Pasteur MSD Products Offered 6.6.5 Sanofi Pasteur MSD Recent Development 6.7 Serum Institute of India 6.6.1 Serum Institute of India Combination Vaccine Production Sites and Area Served 6.6.2 Serum Institute of India Description, Business Overview and Total Revenue 6.6.3 Serum Institute of India Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Serum Institute of India Products Offered 6.7.5 Serum Institute of India Recent Development 6.8 Biokangtai 6.8.1 Biokangtai Combination Vaccine Production Sites and Area Served 6.8.2 Biokangtai Description, Business Overview and Total Revenue 6.8.3 Biokangtai Combination Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Biokangtai Products Offered 6.8.5 Biokangtai Recent Development 7 Combination Vaccine Manufacturing Cost Analysis 7.1 Combination Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Combination Vaccine 7.4 Combination Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Combination Vaccine Distributors List 8.3 Combination Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Combination Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Combination Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Combination Vaccine by Type (2021-2026) 10.2 Combination Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Combination Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Combination Vaccine by Application (2021-2026) 10.3 Combination Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Combination Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Combination Vaccine by Region (2021-2026) 10.4 North America Combination Vaccine Estimates and Projections (2021-2026) 10.5 Europe Combination Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Combination Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Combination Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Combination Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Combination Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Combination Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Combination Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Combination Vaccine Manufacturers Covered in This Study Table 5. Global Combination Vaccine Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Combination Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Combination Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Combination Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Combination Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Combination Vaccine Sales Sites and Area Served Table 11. Manufacturers Combination Vaccine Product Types Table 12. Global Combination Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Combination Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Combination Vaccine as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Combination Vaccine Players Table 16. Global Combination Vaccine Sales (K Units) by Region (2015-2020) Table 17. Global Combination Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Combination Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Combination Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Combination Vaccine Sales by Country (2015-2020) (K Units) Table 21. North America Combination Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Combination Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Combination Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Combination Vaccine Sales by Country (2015-2020) (K Units) Table 25. Europe Combination Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Combination Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Combination Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Combination Vaccine Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Combination Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Combination Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Combination Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Combination Vaccine Sales by Country (2015-2020) (K Units) Table 33. Latin America Combination Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Combination Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Combination Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Combination Vaccine Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Combination Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Combination Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Combination Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Combination Vaccine Sales (K Units) by Type (2015-2020) Table 41. Global Combination Vaccine Sales Share by Type (2015-2020) Table 42. Global Combination Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Combination Vaccine Revenue Share by Type (2015-2020) Table 44. Global Combination Vaccine Price (USD/Unit) by Type (2015-2020) Table 45. Global Combination Vaccine Sales (K Units) by Application (2015-2020) Table 46. Global Combination Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Combination Vaccine Sales Growth Rate by Application (2015-2020) Table 48. GSK Combination Vaccine Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. GSK Main Product Table 52. GSK Recent Development Table 53. Sanofi Pasteur Combination Vaccine Corporation Information Table 54. Sanofi Pasteur Corporation Information Table 55. Sanofi Pasteur Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Sanofi Pasteur Main Product Table 57. Sanofi Pasteur Recent Development Table 58. Merck Combination Vaccine Corporation Information Table 59. Merck Corporation Information Table 60. Merck Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Merck Main Product Table 62. Merck Recent Development Table 63. Pfizer Combination Vaccine Corporation Information Table 64. Pfizer Corporation Information Table 65. Pfizer Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Pfizer Main Product Table 67. Pfizer Recent Development Table 68. CNBG Combination Vaccine Corporation Information Table 69. CNBG Corporation Information Table 70. CNBG Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. CNBG Main Product Table 72. CNBG Recent Development Table 73. Sanofi Pasteur MSD Combination Vaccine Corporation Information Table 74. Sanofi Pasteur MSD Corporation Information Table 75. Sanofi Pasteur MSD Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Sanofi Pasteur MSD Main Product Table 77. Sanofi Pasteur MSD Recent Development Table 78. Serum Institute of India Combination Vaccine Corporation Information Table 79. Serum Institute of India Corporation Information Table 80. Serum Institute of India Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Serum Institute of India Main Product Table 82. Serum Institute of India Recent Development Table 83. Biokangtai Combination Vaccine Corporation Information Table 84. Biokangtai Corporation Information Table 85. Biokangtai Combination Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Biokangtai Main Product Table 87. Biokangtai Recent Development Table 88. Sales Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Combination Vaccine Distributors List Table 91. Combination Vaccine Customers List Table 92. Market Key Trends Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 94. Key Challenges Table 95. Global Combination Vaccine Sales (K Units) Forecast by Type (2021-2026) Table 96. Global Combination Vaccine Sales Market Share Forecast by Type (2021-2026) Table 97. Global Combination Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 98. Global Combination Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 99. Global Combination Vaccine Sales (K Units) Forecast by Application (2021-2026) Table 100. Global Combination Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 101. Global Combination Vaccine Sales (K Units) Forecast by Region (2021-2026) Table 102. Global Combination Vaccine Sales Market Share Forecast by Region (2021-2026) Table 103. Global Combination Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 104. Global Combination Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Combination Vaccine Figure 2. Global Combination Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Meningococcal Vaccine Product Picture Figure 4. Japanese Encephalitis Vaccine Product Picture Figure 5. Yellow Fever Vaccine Product Picture Figure 6. Hepatitis Vaccine Product Picture Figure 7. Cholera Vaccine Product Picture Figure 8. Other Product Picture Figure 9. Global Combination Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 10. Adults Figure 11. Children Figure 12. Global Combination Vaccine Market Size 2015-2026 (US$ Million) Figure 13. Global Combination Vaccine Sales Capacity (K Units) (2015-2026) Figure 14. Global Combination Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Combination Vaccine Sales Share by Manufacturers in 2020 Figure 16. Global Combination Vaccine Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Combination Vaccine Revenue in 2019 Figure 18. Combination Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Combination Vaccine Sales Market Share by Region (2015-2020) Figure 20. Global Combination Vaccine Sales Market Share by Region in 2019 Figure 21. Global Combination Vaccine Revenue Market Share by Region (2015-2020) Figure 22. Global Combination Vaccine Revenue Market Share by Region in 2019 Figure 23. North America Combination Vaccine Sales Market Share by Country in 2019 Figure 24. North America Combination Vaccine Revenue Market Share by Country in 2019 Figure 25. U.S. Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 26. U.S. Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 28. Canada Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Combination Vaccine Sales Market Share by Country in 2019 Figure 30. Europe Combination Vaccine Revenue Market Share by Country in 2019 Figure 31. Germany Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 32. Germany Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 34. France Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 36. U.K. Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 38. Italy Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 40. Russia Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Combination Vaccine Sales Market Share by Region in 2019 Figure 42. Asia Pacific Combination Vaccine Revenue Market Share by Region in 2019 Figure 43. China Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 44. China Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 46. Japan Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 48. South Korea Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 50. India Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 52. Australia Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 54. Taiwan Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 56. Indonesia Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 58. Thailand Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 60. Malaysia Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 62. Philippines Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 64. Vietnam Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Combination Vaccine Sales Market Share by Country in 2019 Figure 66. Latin America Combination Vaccine Revenue Market Share by Country in 2019 Figure 67. Mexico Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 68. Mexico Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 70. Brazil Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 72. Argentina Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Combination Vaccine Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Combination Vaccine Revenue Market Share by Country in 2019 Figure 75. Turkey Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 76. Turkey Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 78. Saudi Arabia Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Combination Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 80. U.A.E Combination Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Combination Vaccine by Type (2015-2020) Figure 82. Sales Market Share of Combination Vaccine by Type in 2019 Figure 83. Revenue Share of Combination Vaccine by Type (2015-2020) Figure 84. Revenue Market Share of Combination Vaccine by Type in 2019 Figure 85. Global Combination Vaccine Sales Growth by Type (2015-2020) (K Units) Figure 86. Global Combination Vaccine Sales Market Share by Application (2015-2020) Figure 87. Global Combination Vaccine Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Combination Vaccine by Application (2015-2020) Figure 89. Global Revenue Share of Combination Vaccine by Application in 2020 Figure 90. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. CNBG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Sanofi Pasteur MSD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Biokangtai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Price Trend of Key Raw Materials Figure 99. Manufacturing Cost Structure of Combination Vaccine Figure 100. Manufacturing Process Analysis of Combination Vaccine Figure 101. Combination Vaccine Industrial Chain Analysis Figure 102. Channels of Distribution Figure 103. Distributors Profiles Figure 104. Porter's Five Forces Analysis Figure 105. North America Combination Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 106. North America Combination Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Europe Combination Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 108. Europe Combination Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Latin America Combination Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Combination Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa Combination Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Combination Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific Combination Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Combination Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Bottom-up and Top-down Approaches for This Report Figure 116. Data Triangulation Figure 117. Key Executives Interviewed

GSK Sanofi Pasteur Merck Pfizer CNBG Sanofi Pasteur MSD Serum Institute of India Biokangtai